Market revenue in 2024 | USD 663.1 million |
Market revenue in 2030 | USD 1,005.4 million |
Growth rate | 7.2% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 47.58% in 2024. Horizon Databook has segmented the Italy cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
CVDs, including heart failure and arrhythmias, are the leading cause of death in Italy. This growing burden translates to increased demand for CRMs in diagnosis & treatment. According to the American Heart Association Journal 2022, in Italy, a country with approximately 60 million inhabitants, cardiovascular diseases contribute to nearly half of all fatalities, accounting for 44% of total deaths.
Ischemic heart disease stands out as the primary cause of mortality, responsible for 28% of these fatalities. Furthermore, cardiac arrest cases increased in Italy, primarily due to a scarcity of resources during the pandemic. This amplified the demand for defibrillators in the country.
According to the ECHOES Srl, cardiac arrest cases increased by more than 60% in 2020 compared to 2019. CRM devices are used to treat cardiac arrest. These devices work by helping to regulate the heart's electrical signals, which can be disrupted during cardiac arrest.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Italy cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account